Laryngeal dystonia as a presenting symptom of young-onset Parkinson's disease [4]

Movement Disorders

Volumn 22, Issue 11, 2007, Pages 1670-1671

  Papapetropoulos, Spiridon ^a   Lundy, Donna S ^a   Casiano, Roy R ^a   Singer, Carlos ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; BOTULINUM TOXIN A; LEVODOPA; PERGOLIDE; ROPINIROLE; SELEGILINE; TRIHEXYPHENIDYL;

ADD ON THERAPY; ADULT; BRADYKINESIA; CASE REPORT; CLINICAL FEATURE; DRUG DOSE REDUCTION; DRUG EFFICACY; DYSPHONIA; DYSTONIA; FEMALE; HUMAN; LARYNGOSCOPY; LARYNX DISORDER; LARYNX DYSTONIA; LETTER; LOW DRUG DOSE; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; RIGIDITY; SPEECH DISORDER; TREATMENT DURATION; TREATMENT RESPONSE; TREMOR;

ADULT; FEMALE; HUMANS; LARYNGEAL DISEASES; PARKINSON DISEASE;

EID: 34748892582     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21184     Document Type: Letter

References (7)

1. LeWitt PA, Burns RS, Newman RP. Dystonia in untreated parkinsonism. Clin Neuropharmacol 1986;9:293-297.
2. Katchen M, Duvoisin RC. Parkinsonism following dystonia in three patients. Mov Disord 1986;1:151-157.
3. Klawans HL, Paleologos N. Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists. Clin Neuropharmacol 1986;9:298-302.
4. Poewe WH, Lees AJ, Stern GM. Dystonia in Parkinson's disease: clinical and pharmacological features. Ann Neurol 1988;23:73-78.
5. Kidron D, Melamed E. Forms of dystonia in patients with Parkinson's disease. Neurology 1987;37:1009-1011.
6. Nausieda PA, Weiner WJ, Klawans HL. Dystonic foot response of Parkinsonism. Arch Neurol 1980;37:132-136.
7. Logemann JA, Fisher HB, Boshes B, Blonsky ER. Frequency and cooccurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients. J Speech Hear Disord 1978;43:47-57.